| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |